Navigation Links
Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
Date:11/6/2008

two fiscal quarters, and to provide, update or reconfirm its guidance only by issuing a press release or filing updated guidance with the SEC in a publicly accessible document. Clinical guidance is as of November 6, 2008 and financial guidance relating to the Company's current cash, cash equivalents and investments is as of September 30, 2008.

This press release includes forward-looking statements regarding the development of the Company's product candidates, projected clinical trial enrollment and data reporting timelines, and safety of the Company's products and technologies. Any statement describing a product candidate or Alexza's goals, expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission including the risks under the headings "We have a history of net losses. We expect to continue to incur substantial and increasing net losses for the foreseeable future, and we may never achieve or maintain profitability.", "We will need substantial additional capital in the future. If additional capital is not available, we will have to delay, reduce or cease operations.", "Failure or delay in commencing or completing clinical trials for our product candidates could harm our business.", and "If our product candidates do not meet safety a
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
2. Alexza and Autoliv Announce Commercial Manufacturing and Supply Agreement for Heat Packages Used in Single-Dose Staccato(R) System
3. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference
4. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
5. Alexza to Webcast Investor and Analyst Day Presentations
6. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
7. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
8. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
9. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
10. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 The report ... comprehensive information on the therapeutic development for Muscle ... muscles in the body, leading to many different ... by identifying new targets and MOAs to produce ... 2015 pipeline review of Axillary Hyperhidrosis with 19 ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... and in-depth study on the current state of ... report provides key statistics on the state of ... guidance and direction for companies and individuals interested ... overview of the industry including definitions, classifications, applications ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... giving patients a long-lasting impression on what modern dentistry ... VisitandCare.com is on a mission to revolutionize the perception ... with a high-class Wellness & Spa. , The ... world’s most successful medical tourism agencies and ...
(Date:5/29/2015)... Healthpointe clinics throughout Southern California are now ... their licensed clinical psychologist, Dr. Levon Margolin. Despite ... an extensive array of physical, cognitive, emotional, and behavioral ... time after a traumatic ordeal involving the brain. Traumatic ... jolt to the head that impedes the normal function ...
(Date:5/29/2015)... VA (PRWEB) May 29, 2015 Javlin ... a new U.S. headquarters and a larger team, with ... and increase CloverETL's market share in the U.S. and ... the Javlin Group, achieved significant growth in 2014 with ... of Javlin’s premier data integration platform, CloverETL. To accelerate ...
Breaking Medicine News(10 mins):Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 3Health News:Healthpointe’s Los Angeles County Clinics Are Now Offering Treatment for Mild Traumatic Brain Injuries 2Health News:Growth of Data Integration Platform CloverETL Continues in North America 2
... 18, 2009 While death rates from cancer continue ... be diagnosed at more advanced stages and have lower ... whites for most cancer sites. The findings come from ... latest edition of a report produced every two years ...
... 18 Regardless of where they are born ... screening for many life-threatening disorders, a remarkable public health advance ... issued today by the March of Dimes.All 50 states and ... screened for 21 or more of the 29 serious ...
... & Vein Institute eliminates varicose and spider veins ... 17 Southern California based Renaissance Laser & ... method for eliminating painful and unsightly veins. ... is a common problem. Sun damage, loss ...
... Association Executive Vice President for Public Affairs Beth Johnson ... Court of Appeals decision to uphold a New York ... information should be provided in some of the city,s ... information they want and need is for the federal ...
... Critical Support to Hispanic Family BudgetsWASHINGTON, Feb. 17 ... National Alliance for Hispanic Health, the nation,s leading Hispanic ... signing of the American Recovery and Reinvestment Act by ... environment, millions of Hispanic families are an illness or ...
... to prescribe popular cholesterol-lowering drugs called statins would produce cost-effective results ... followed more closely by physicians and patients, according to a new ... , ... (Vocus) February 17, 2009 -- Current guidelines ...
Cached Medicine News:Health News:Cancer death rates dropping among African Americans but survival rates still low 2Health News:Cancer death rates dropping among African Americans but survival rates still low 3Health News:States Expand Newborn Screening for Life-Threatening Disorders; New March of Dimes Report Finds State-By-State Gaps Nearly Eliminated 2Health News:States Expand Newborn Screening for Life-Threatening Disorders; New March of Dimes Report Finds State-By-State Gaps Nearly Eliminated 3Health News:States Expand Newborn Screening for Life-Threatening Disorders; New March of Dimes Report Finds State-By-State Gaps Nearly Eliminated 4Health News:Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Provides Top Notch 'Varicose Vein Treatment' 2Health News:National Restaurant Association Statement Regarding Federal Court Ruling on Menu Labeling in New York City 2Health News:Statement of the National Alliance for Hispanic Health on Signing of the American Recovery and Reinvestment Act 2Health News:Statins Pay Off on a Health-Policy Level, UCSF Study Finds 2Health News:Statins Pay Off on a Health-Policy Level, UCSF Study Finds 3Health News:Statins Pay Off on a Health-Policy Level, UCSF Study Finds 4
(Date:5/28/2015)... and HOUSTON , May 28, 2015 /PRNewswire/ ... today reported financial results for the second quarter and three ... otherwise, are expressed in Canadian dollars and in accordance with ... ESSA recorded a net loss of $5.9 ... March 31, 2015 (Q2-2015), compared to a net loss of ...
(Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ...  to their offering.       (Logo: ... gene silencing involves the use of double ... this material is processed into short 21-23 ...
(Date:5/28/2015)... MELVILLE, N.Y. , May 28, 2015 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, today reminded its customers that ... for dentists, physicians and veterinarians who experience operational, ... the disastrous storms in the South Central region ...
Breaking Medicine Technology:Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3
... 5 Abbott (NYSE: ABT ) will present at the ... in New York City .  Miles D. White, chairman and chief ... a.m. Central time . , , ... audio webcast of the presentation will be accessible through Abbott,s Investor Relations Web ...
... is available in its catalogue: , , , ... http://www.reportlinker.com/p0187226/The-World-Anesthesia-Drug-Market.html , ... Drug Market - focuses on three primary segments of anesthesia: , , , ... , , , ...
Cached Medicine Technology:Reportlinker Adds The World Anesthesia Drug Market 2Reportlinker Adds The World Anesthesia Drug Market 3Reportlinker Adds The World Anesthesia Drug Market 4Reportlinker Adds The World Anesthesia Drug Market 5Reportlinker Adds The World Anesthesia Drug Market 6Reportlinker Adds The World Anesthesia Drug Market 7Reportlinker Adds The World Anesthesia Drug Market 8Reportlinker Adds The World Anesthesia Drug Market 9Reportlinker Adds The World Anesthesia Drug Market 10
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: